The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.
Issue link: https://skincancer.epubxp.com/i/65757
1Therapy 2Steps High Clearance Low Down Time ** Physician-Controlled Therapy *At 8 weeks, 77% of patients treated with Levulan PDT experienced 75% clearance of AK lesions vs 23% of the control group. 83% of the patients treated with Levulan PDT had 75% clearance of face lesions and 60% of the patients had 75% clear ance of scalp lesions. 66% of patients treated with Levulan PDT experienced 100% clearance of AK lesions vs 13% of the control group. 70% of the patients treated with Levulan PDT had 100% clearance of face lesions and 55% of the patients had 100% clearance of scalp lesions. Important Risk Information The Levulan® Kerastick® for Topical Solution plus blue light illumination using the BLU-U® Blue Light Photodynamic Therapy Illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. Contraindicated in patients with cutaneous photosensitivity at wavelengths of 400-450 nm, porphyria, or known allergies to porphyrins, and in patients with known sensitivity to any of the components of the Levulan Kerastick for Topical Solution. The most common adverse events include scaling/crusting, hypo/hyperpigmentation, itching, stinging and/or burning, erythema and edema. Severe stinging and/or burning at one or more lesions being treated was reported by at least 50% of patients at some time during the treatment. Following treatment, the treated AKs and to some degree the surrounding skin may redden, and swelling and scaling may also occur. However, these effects are temporary and should completely resolve by 4 weeks after treatment. **Patients treated with Levulan PDT should avoid exposure of the photosensitized lesions to sunlight or prolonged or intense light for at least 40 hours. 1. Levulan® Kerastick® Prescribing Information, DUSA Pharmaceuticals, Inc.® Please see safety information on adjacent page. Levulan® , Kerastick® www.levulan.com and BLU-U® are registered trademarks of DUSA Pharmaceuticals, Inc.® MKT-1665AW Rev A 1* 3Reasons to use